Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Operating Expenses

$9.81M

Quarterly · Period ending: Jun 30, 2026 · USD

LCTX Operating Expenses

Latest reported$9.81Mperiod endingJun 30, 2026

Latest reported$9.81Mperiod endingJun 30, 2026

LCTX Quarterly Operating Expenses ($100.00K → $9.81M)

Quarterly operating expenses

High-resolution chart · PNG

LCTX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Operating Expenses — Quarterly (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2001	1,155,384
Mar 31, 2001	990,889
Dec 31, 2000	1,112,153
Sep 30, 2000	1,305,036
Jun 30, 2000	1,397,389
Mar 31, 2000	1,403,652
Dec 31, 1999	1,556,751
Sep 30, 1999	2,400,000
Jun 30, 1999	1,700,000
Mar 31, 1999	1,200,000
Sep 30, 1998	1,300,000
Jun 30, 1998	1,100,000
Mar 31, 1998	1,300,000
Dec 31, 1997	1,300,000
Sep 30, 1997	1,200,000
Jun 30, 1997	1,200,000
Mar 31, 1997	600,000
Dec 31, 1996	800,000
Sep 30, 1996	700,000
Jun 30, 1996	-2,100,000
Mar 31, 1996	0
Dec 31, 1995	0
Sep 30, 1995	300,000
Jun 30, 1995	800,000
Mar 31, 1995	600,000
Dec 31, 1994	700,000
Sep 30, 1994	500,000
Jun 30, 1994	600,000
Mar 31, 1994	300,000
Dec 31, 1993	200,000
Sep 30, 1993	200,000
Jun 30, 1993	200,000
Mar 31, 1993	200,000
Dec 31, 1992	200,000
Sep 30, 1992	200,000
Jun 30, 1992	200,000
Mar 31, 1992	100,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.